Cite Filings / HRTX / 0001193125-19-261632
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B5

Prospectus

HERON THERAPEUTICS, INC. /DE/ · Filed 2019-10-03 · Acc 0001193125-19-261632

Documents 1

  • 424B5 Prospectus , d793993d424b5.htm

Around this filing

  • 2022-10-20 424B5 Prospectus
  • 2019-10-04 4 Chief Executive Officer bought 4,571 shares at $17.50 ($79,993)
  • 2019-10-04 4 EVP, Chief Commercial Officer bought 5,143 shares at $17.50 ($90,003)
  • 2019-10-03 424B5 Prospectus
  • 2019-10-02 8-K Regulation FD disclosure · Other events
  • 2019-10-01 3 Initial Statement of Ownership
  • 2018-06-27 424B5 Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d793993d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…